The combination of curcumin and EGCG downregulates IL-8 expression and inhibits the inflammatory response in the tumor microenvironment of colon cancer by suppressing the JAK/STAT3 signaling pathway [223]. This evidence concerns the gene CXCL8 and neoplasm.